News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
270
Sources here
20
Companies here
5
Search results Stored financial headlines

Active search

270 matching headlines

Ticker or company: UTLMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Outlook Therapeutics to Report Q3 Earnings: What's in the Cards?

We expect Outlook Therapeutics OTLK to beat expectations when it reports third-quarter fiscal 2026 results later this month. In the last reported quarter, the company delivered a negative earnings surprise of 33.33%. The Zacks Consensus Estimate for revenues is pegged at $1.20 million, while …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avoiding Lag: Real-Time Signals in (UTL) Movement

This article provides real-time signal analysis for Unitil Corporation (UTL), indicating a near-term neutral sentiment amidst mid and long-term strength. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, showing support and resistance levels. The analysis highlights …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tanger Inc. (NYSE:SKT) Receives Consensus Rating of "Hold" from Analysts

Analysts have issued a consensus "Hold" rating for Tanger Inc. (NYSE:SKT), with an average 12-month price target of $39.70, which is slightly below the current share price. The company reported mixed quarterly results, with revenue exceeding estimates but EPS missing consensus. Tanger also announced …

SKT main company
Sharemaestro market context Trend signal active 52 weeks +17.8% · Next-week setup positive 59.6% SKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics, Inc. Revenue Breakdown – NASDAQ:OTLK

Outlook Therapeutics, Inc. (NASDAQ: OTLK) reported a revenue of $1.41 million USD last year, primarily from its Ophthalmic Formulation segment, a decrease from $8.15 million USD the previous year. The United States was the largest contributor to this revenue. The company's financial overview highlights …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ollie's (OLLI) Stock Looks Reasonable On Cash Flow While Earnings Look Stretched

Ollie's Bargain Outlet Holdings (OLLI) stock has seen a significant price drop over the past year. While a Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by approximately 22.3%, indicating a reasonable valuation based on its cash flow potential, market-based P/E multiples …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 4 Ollies Bargain Outlet Holdings Inc For: 31 July By Investing.com

This article reports on a Form 4 filing for Ollie's Bargain Outlet Holdings Inc. on July 31st, as reported by Investing.com. The content of the Form 4 filing itself is not detailed in the provided text, which primarily consists of market data and other …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UTL|Unitil Corp|Price:53.940|Chg%:-0.510

This article provides a comprehensive stock analysis of Unitil Corp (UTL) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fairly valued status. The company is a high dividend payer with stable dividends and strong institutional ownership, including investor Paul Tudor Jones. While …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Outlook Therapeutics (OTLK) Fully Valued As FDA Approval Reshapes Its Prospects?

Outlook Therapeutics (OTLK) recently received FDA approval for LYTENAVA, its ophthalmic bevacizumab, for neovascular age-related macular degeneration, significantly impacting its investment outlook. Despite a near 3x share price increase in 90 days, followed by a 34.59% drop in 30 days, the company's valuation is …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings To Watch: Unitil Corp (UTL) Q2 2026 -- GF Value Sees 5% Downside

Unitil Corp (UTL) is scheduled to release its Q2 2026 earnings on August 3, 2026, with revenue expected to be $113.15 million and earnings at $0.25 per share. While analysts project a slight upside of 1.53% based on average price targets, GuruFocus's GF Value …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tanger Inc's Dividend Analysis

This article first appeared on GuruFocus. Assessing the Upcoming Payout and Long-Term Sustainability of Tanger Inc (NYSE:SKT) Tanger Inc (NYSE:SKT) recently announced a total dividend of $0.31 per share, with the ex-dividend date set for 2026-07-31. This payment includes a $0.31 per share cash …

SKT main company
Sharemaestro market context Trend signal active 52 weeks +17.8% · Next-week setup positive 59.6% SKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Corp (UTL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Unitil Corp (UTL), detailing its current risk score of 8.92, which ranks 12th out of 12 in the Multiline Utilities industry. Key metrics include a beta of 0.32, indicating lower volatility compared to the S&P 500, along …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Grocery Outlet Holding Corp (GO) Financial Health: Profitability & Balance Sheet Analysis

Grocery Outlet Holding Corp (GO) holds a financial score of 7.49, ranking 8th out of 30 in the Food & Drug Retailing industry, indicating stable financial health and average operating efficiency. The company recently reported a quarterly revenue of $1.17 billion, marking a 3.62% …

GO main company
Sharemaestro market context Trend signal active 52 weeks -40.3% · Next-week setup negative 40.6% GO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wet AMD Drug Secures First FDA-Approved Bevacizumab Status

Outlook Therapeutics Inc. (OTLK:NASDAQ) has received FDA approval for LYTENAVA, making it the first FDA-approved ophthalmic bevacizumab for wet age-related macular degeneration (wet AMD). This approval opens up access to an estimated US$8.5 billion U.S. market and is expected to provide 12 years of …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RBC Cuts Price Target on Ollie's Bargain Outlet Holdings to $121 From $152, Keeps Outperform Rating

RBC has adjusted its price target for Ollie's Bargain Outlet Holdings (OLLI) to $121, down from $152, while maintaining an Outperform rating on the stock. Despite this reduction, the average analyst rating for OLLI remains a "buy" with a mean price target of $107.07, …

OLLI main company
Sharemaestro market context Price below Trend Line 52 weeks -42.1% OLLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics (OTLK) Stock Looks Cheap On Hope But Pricey On Book Value

Outlook Therapeutics (OTLK) has seen a significant stock decline over five years, but recent FDA approval for its lead drug, LYTENAVA, has brought renewed attention. While the approval provides hope for improved revenues, the stock's valuation picture remains inconclusive due to a negative shareholder …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Corp (UTL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Unitil Corp (UTL), focusing on its current price momentum, support and resistance levels, and insights from various technical indicators and moving averages. According to the analysis, UTL's current price momentum score is 2.91, ranking 2nd in its …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Corp (UTL) Institutional Confidence

Unitil Corp (UTL) has a high institutional shareholding score of 10.00, placing it first in the Multiline Utilities industry. The institutional shareholding proportion is 92.08%, an 11.19% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 2.72% of outstanding shares.

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Corp (UTL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Unitil Corp (UTL), highlighting its current valuation score of 7.52, which ranks it 4th in the Multiline Utilities industry. The company's P/E ratio is 17.49, sitting between its recent high and low. Data for P/B, P/S, and …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics (OTLK) Is Down 24.3% After Landmark FDA Wet AMD Drug Approval - Has The Bull Case Changed?

Outlook Therapeutics (OTLK) shares dropped 24.3% following FDA approval for LYTENAVA, a drug for wet age-related macular degeneration, despite securing 12 years of exclusivity in an $8.5 billion market. The investment focus has shifted from approval to successful U.S. launch and reimbursement, but financing …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Grocery Outlet Holding Corp (GO) Institutional Confidence

Grocery Outlet Holding Corp (GO) has an institutional shareholding score of 10.00, placing it first in the Food & Drug Retailing industry. The institutional shareholding proportion is 121.11%, a decrease of 10.66% quarter-over-quarter. HOTCHKIS & WILEY is the largest institutional shareholder with 874.54K shares, …

GO main company
Sharemaestro market context Trend signal active 52 weeks -40.3% · Next-week setup negative 40.6% GO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UNITIL Number of Employees 2026 | Employee Count & Headcount Data

Revelio Labs data shows that UNITIL Corp. (UTL) had approximately 610 employees worldwide as of March 2026, marking a 5.9% growth from 2023. Despite this growth, the total headcount decreased by 0.8% year-over-year in 2026. The company is actively hiring, with 13 active job …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2026 Earnings Release and Conference Call Date

Grocery Outlet Holding Corp. (NASDAQ: GO) announced that its financial results for the second quarter of fiscal 2026 will be released after market close on Wednesday, August 12, 2026. The company will host a conference call at 4:30 PM ET to discuss these results, …

GO main company
Sharemaestro market context Trend signal active 52 weeks -40.3% · Next-week setup negative 40.6% GO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics (OTLK) director purchases 95,398 common shares

Outlook Therapeutics director Faisal Ghiath Sukhtian purchased 95,398 shares of common stock at $1.0482 per share on July 29, 2026. This transaction increased his direct holdings to 220,972 common shares. The purchase was an open-market or private transaction and was not made under a …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Corporation (NYSE:UTL) Declares $0.47 Quarterly Dividend

Unitil Corporation (NYSE:UTL) announced a quarterly dividend of $0.475 per share, payable on August 31st to shareholders of record by August 17th. The utility provider has consistently increased its dividend for the past 12 years and maintains a payout ratio of 57.8%, indicating sufficient …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GO|Grocery Outlet Holding Corp|Price:8.861|Chg%:-0.279

This article provides a detailed company profile for Grocery Outlet Holding Corp. (GO), including its business scope, financial data, and market performance. It highlights the company's retail model operating through independently owned stores across multiple states, its product offerings, distribution network, and key executives. …

GO main company
Sharemaestro market context Trend signal active 52 weeks -40.3% · Next-week setup negative 40.6% GO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejection

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. On Friday, the U.S. Food and Drug Administration (FDA) approved Outlook Therapeutics Inc.'s ONS-5010/LYTENAVA (bevacizumab-vikg, bevacizumab gamma) for neovascular age-related macular degeneration (nAMD), commonly known as wet …

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil declares $0.475 quarterly dividend payable Aug. 31

Unitil Corporation has announced a regular quarterly dividend of $0.475 per share, payable on August 31, 2026, to shareholders of record as of August 17, 2026. This translates to an annualized dividend rate of $1.90 per share. Unitil is a public utility holding company …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil Declares Common Stock Dividend

Unitil Corporation announced that its Board of Directors declared a regular quarterly dividend of $0.475 per share on its common stock. This dividend is payable on August 31, 2026, to shareholders of record as of August 17, 2026, resulting in an annualized dividend rate …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unitil’s next shareholder payout is due Aug. 31 at $0.475

Unitil (NYSE: UTL) recently declared a regular quarterly dividend of $0.475 per common share. This dividend will be payable on August 31, 2026, to shareholders of record as of August 17, 2026, resulting in an effective annualized dividend rate of $1.90 per share. The …

UTL main company
Sharemaestro market context Trend signal active 52 weeks +17.2% UTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tanger Inc stock hits 52-week high at 42.05 USD

Tanger Inc. (SKT) stock has hit a 52-week high of $42.05, driven by a nearly 39% one-year return and a 31% gain in the past six months, reflecting strong investor confidence. Despite an InvestingPro analysis suggesting the stock is overvalued based on Fair Value, …

SKT main company
Sharemaestro market context Trend signal active 52 weeks +17.8% · Next-week setup positive 59.6% SKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tanger (SKT) to Release Earnings on Tuesday

Tanger (SKT) is scheduled to release its Q2 2026 earnings after market close on Tuesday, August 4th, with analysts expecting $0.25 per share and $142.6 million in revenue. The company recently declared a quarterly dividend of $0.3125 per share, representing a 3.0% annualized yield. …

SKT main company
Sharemaestro market context Trend signal active 52 weeks +17.8% · Next-week setup positive 59.6% SKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Grocery Outlet (GO) Expected to Announce Quarterly Earnings on Tuesday

Grocery Outlet (GO) is anticipated to release its Q2 2026 earnings on Tuesday, August 4th, with analysts projecting earnings of $0.12 per share and revenue of $1.167 billion. The company has provided a fiscal 2026 EPS guidance of $0.45–$0.55. Despite beating prior quarter estimates, …

GO main company
Sharemaestro market context Trend signal active 52 weeks -40.3% · Next-week setup negative 40.6% GO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Outlook Therapeutics, Inc. (NASDAQ:OTLK): When Will It Breakeven?

This article examines when Outlook Therapeutics, Inc. (NASDAQ:OTLK) is expected to achieve breakeven profitability. It analyzes the company's financial performance and projections to forecast its path to profitability. The analysis helps investors understand the timeline for OTLK to become financially self-sufficient.

OTLK main company
Sharemaestro market context Trend signal active 52 weeks -71.8% OTLK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context